1 Min Read
Nov 2 (Reuters) - Juniper Pharmaceuticals Inc
* Juniper Pharmaceuticals reports third quarter 2017 financial and operating results
* Q3 loss per share $0.13
* Q3 revenue rose 12 percent to $13 million Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.